ReviewJournal of hepatocellular carcinoma2021

The Role of Cabozantinib as a Therapeutic Option for Hepatocellular Carcinoma: Current Landscape and Future Challenges.

Antonio D'Alessio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.